콘텐츠로 건너뛰기
Merck
모든 사진(1)

주요 문서

PURX60005

Sigma-Aldrich

Pur-A-Lyzer Maxi Dialysis Kit

Maxi 6000, capacity 0.1-3 mL, pkg of 5 Maxi dialysis tubes, MWCO 6-8 kDa

동의어(들):

Dialyzers, High through put dialysis tubing, puralyzer

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41123100
NACRES:
NB.22

material

regenerated cellulose membrane

포장

pkg of 5 Maxi dialysis tubes

용량

0.1-3 mL

튜브 길이 × 직경

8 cm × 2.2 cm

공극 크기

6-8 kDa MWCO

유사한 제품을 찾으십니까? 방문 제품 비교 안내

일반 설명

The Pur-A-Lyzer Dialysis Kits are an innovative dialysis tubing that can be conveniently loaded and unloaded using any standard pipette tip while still allowing for 98% sample recovery yield. The revolutionary design of the Pur-A-Lyzer Tube makes it the only dialysis tool which enables true high throughput dialysis, accommodating a large number of samples in a single buffer tank.

The Pur-A-Lyzer Dialysis Tube allows rapid, high performance extraction of macromolecules without contamination. It is ideal for purification of proteins, automated protein sequencing, peptide mapping and amino acid analysis.

애플리케이션

  • Dialysis or buffer exchange of volumes between 10 mL and 20 mL
  • Preparation of protein samples for MALDI-MS
  • Sample concentration
  • Large-scale protein dialysis such as antibodies and recombinant protein purification
  • Peptide dialysis for molecules as small as 10 amino acids
  • Virus-particle purification
  • Removal of contaminating micro molecules
  • Purification of tissue culture extracts
  • Removal of salts, surfactants, solvents and detergents
  • Complex formation studies (protein-protein, protein-DNA and protein-RNA)
  • pH and buffer adjustment of sample solution, protein extract or cell extract
  • High through- put dialysis, a single beaker can be used for several Pur-A-Lyzer tubes on one floating pad

For your convenience the Pur-A-Lyzer kits come in four sizes:
Mini: 10-250 μL
Midi: 50-800 μL
Maxi: 0.1-3 mL
Mega: 3-20 mL

법적 정보

Pur-A-Lyzer is a trademark of Sigma-Aldrich Co. LLC

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

죄송합니다. 지금은 이 제품에 대한 COA이(가) 온라인에서 제공되지 않습니다.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Andrew S Flies et al.
Frontiers in immunology, 7, 581-581 (2016-12-27)
The devil facial tumor disease (DFTD) is caused by clonal transmissible cancers that have led to a catastrophic decline in the wild Tasmanian devil (Sarcophilus harrisii) population. The first transmissible tumor, now termed devil facial tumor 1 (DFT1), was first
Andrew S Flies et al.
Science advances, 6(27) (2020-09-17)
Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to less than 10% for most species. In addition, devils are affected by two of the three known transmissible cancers in mammals. Immune checkpoint immunotherapy

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.